Drug
Edit 101
Edit 101: highest development phase Phase 1/2, developed by Editas Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Editas Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| EDIT-101 NCT03872479 | Phase 1/2 | Leber Congenital Amaurosis 10 |
Latest
No recent events.
Follow Edit 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.